CMS Drops QRS Restriction From Defibrillator Policy, Requires Registry
This article was originally published in The Gray Sheet
Executive Summary
Guidant will lobby CMS to reconsider the COMPANION CRT-D trial data before finalizing a new implantable cardioverter defibrillator coverage policy
You may also be interested in...
Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005
The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input from 35 individuals, organizations, and companies during the initial public comment period. The agency did not specify any particular issues or deficiencies that it wants to address by updating its coverage policy, but CMS has not reconsidered the national coverage policy on ICDs since a major coverage expansion was implemented in 2005.
Study Finds Gender, Racial Disparities In ICD Referrals
Women and minority men are significantly less likely than white men to receive an implantable cardioverter defibrillator for either primary or secondary prevention of cardiac death, according to studies in the Oct. 3 Journal of the American Medical Association
Study Finds Gender, Racial Disparities In ICD Referrals
Women and minority men are significantly less likely than white men to receive an implantable cardioverter defibrillator for either primary or secondary prevention of cardiac death, according to studies in the Oct. 3 Journal of the American Medical Association